The largest US drugstore operator Walgreens Boots Alliance has made a takeover approach to drug distributor AmerisourceBergen the Wall Street Journal reported on Monday, outlining a deal that would accelerate healthcare sector consolidation.
Walgreens is valued at $67.82 billion and AmerisourceBergen has a market capitalization of US$19.65 billion, according to WSJ.
Healthcare payers and pharmacies are responding to a shifting landscape, including changes in the US Affordable Care Act, rising drug prices and the threat of competition from online retailers such as Amazon.com.
A new deal by Walgreens would follow the US$69 billion acquisition of health insurer Aetna Inc by drugstore rival CVS Health Corp and would also reflect a move toward vertical consolidation, where members of a supply chain combine.
Full Content: The Wall Street Journal
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Alaska Airlines’ Hawaiian Acquisition Faces Antitrust Scrutiny
Dec 6, 2023 by
CPI
Ulmer & Greensfelder Merge to Form UB Greensfelder
Dec 6, 2023 by
CPI
Apple’s iMessage May Be Exempt from New EU Regulations
Dec 6, 2023 by
CPI
UK Watchdog Warns Firms on AI Privacy Compliance
Dec 6, 2023 by
CPI
FTC Mounts Second Challenge to Microsoft’s Activision Buy Despite Closed Deal
Dec 6, 2023 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Horizontal Competition: Mergers, Innovation & New Guidelines
Nov 30, 2023 by
CPI
Innovation in Merger Control
Nov 30, 2023 by
CPI
Making Sense of EU Merger Control: The Need for Limiting Principles
Nov 30, 2023 by
CPI
Sustainability Agreements in the EU: New Paths to Competition Law Compliance
Nov 30, 2023 by
CPI
Merger Control and Sustainability: A New Dawn or Nothing New Under the Sun?
Nov 30, 2023 by
CPI